Clinical Trial Update: Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the addition of Telomelysin to chemoradiation for patients with advanced esophageal or gastroesophageal junction adenocarcinoma who are…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Telomelysin (OBP-301)

Snippet

Sponsor: NRG Oncology | Conditions: Advanced Esophageal Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-05-29